QTc prolongation during the SARS-CoV-2 outbreak: clinical risk management through hospital training course, focus on elderly patients
Submitted: 22 May 2020
Accepted: 22 June 2020
Published: 27 August 2020
Accepted: 22 June 2020
Abstract Views: 683
PDF: 324
HTML: 28
HTML: 28
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Alberto Castagna, Francesco Vetta, Giuseppe Attisani, Raffaele Costa, Carmen Ruberto, Viviana Vespertini, Lucio Cosco, Giovanni Ruotolo, Hydroxychloroquine and QTc: beyond COVID-19 , Geriatric Care: Vol. 6 No. 3 (2020)
- Giovanni Cenderello, Simone Dini, Serena Ziliani, Crocefissa Fiorella Casuccio, Francesca Mori Ubaldini, COVID-19 treatment in the older people: a brief clinical review , Geriatric Care: Vol. 6 No. 3 (2020)
You may also start an advanced similarity search for this article.